Correlation Engine 2.0
Clear Search sequence regions


  • antigen (1)
  • B7 H3 (1)
  • blood (1)
  • chronic pain (1)
  • chronic pelvic pain (1)
  • CPPS (2)
  • diagnosis (3)
  • humans (1)
  • interleukin- 6 (1)
  • interleukin- 8 (1)
  • macrophage (2)
  • MCP 1 (1)
  • MIP 1α (1)
  • mip- 3 (1)
  • monocyte (1)
  • NGF (1)
  • pelvic pain (1)
  • platelet (1)
  • prostate (1)
  • research (1)
  • semen (1)
  • serum (2)
  • Sizes of these terms reflect their relevance to your search.

    At present, there are no widely accepted specific biomarkers for the experimental diagnosis of chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS). Recent studies show that many related biomarkers exist in expressed prostatic secretions (EPS) or semen, urine and blood or serum. The monocyte chemotactic protein-1 (MCP-1/CCL-2), macrophage-inflammatory-protein-1 alpha (MIP-1α/CCL-3), interleukin-6 (IL-6), interleukin-8 (IL-8), nerve growth factor (NGF) and B7-H3 in EPS, prostatic exosomal protein (PSEP) in the urine, and prostate-specific antigen (PSA), mean platelet volume (MPV) and macrophage migration inhibitory factor (MIF) in the serum are believed to be of significant clinical and research value, and expected to become important laboratory biomarkers for the diagnosis of CP/CPPS.

    Citation

    Cheng-Quan Ma, Jian Xiong, Hong-Jun Li. Advances in the studies of special biomarkers for the experimental diagnosis of CP/CPPS]. Zhonghua nan ke xue = National journal of andrology. 2020 Jul;26(7):660-665

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33377725

    View Full Text